Home / Trials and Studies/ Trial or Study

Timing of Initiation of Renal-Replacement Therapy of Acute Kidney Injury (STARRT-AKI)

Principal Investigator(s):

Sean Bagshaw, Ron Wald

Status: Enrolment Complete

The STARRT-AKI trial is an international, multi-center, open-label, randomized controlled trial that compared an accelerated strategy to the initiation of RRT versus a conservative strategy to the initiation of RRT, as guided by standard indications and clinical judgement in critically ill patients with AKI, on 90-day all-cause mortality (primary), RRT dependence (secondary) and a spectrum of additional outcomes.

Key publications:

STARRT-AKI main trial

STARRT-AKI protocol

STARRT-AKI statistical analysis plan

Secondary publications:

STARRT-AKI (Equipoise)

STARRT-AKI (Bayesian Re-analysis)

STARRT-AKI (RRT Baseline Risk)

Program publications:



STARRT-AKI pilot protocol

CANAKI II study (observational)

CANAKI I study (observational)

CANAKI study (survey of practice)

Systematic Review

For more Information, visit the STARRT-AKI trial website

Participating Centres:

List of participating centres


List of Co-Investigators